☆ 4.6 Review

Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease

FRONTIERS IN NEUROSCIENCE (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Intermittent fasting protects the nigral dopaminergic neurons from MPTP-me diate d dopaminergic neuronal injury in mice

Uttam Ojha et al.

Summary: This study investigated the neuroprotective effects of fasting in a mouse model of Parkinson's disease. The findings showed that alternate-day fasting attenuated dopaminergic neuronal loss and astroglial activation in the brain, reduced depletion of striatal dopamine, improved motor impairment caused by MPTP, and increased the phosphorylation of signaling molecules involved in neurotrophic factors.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2023)

Add to Collection

Article Endocrinology & Metabolism

D-beta-hydroxybutyrate protects against microglial activation in lipopolysaccharide-treated mice and BV-2 cells

Yuping Zhang et al.

Summary: This study investigates the protective effects of D-beta-hydroxybutyrate (BHB) against microglial activation and neuroinflammation in mice and BV-2 cells. BHB treatments attenuated behavioral abnormalities, reduced the number of activated microglia, and decreased the levels of inflammatory cytokines while promoting the production of neuroprotective factors. These findings suggest that BHB has potential as a treatment for neurological disorders.

METABOLIC BRAIN DISEASE (2023)

Add to Collection

Article Clinical Neurology

Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort

Pratishtha Chatterjee et al.

Summary: This study investigated the changes in several blood biomarkers across the AD continuum and their associations with cognitive decline and brain Aβ-PET load. The results showed that plasma Aβ1-42/Aβ1-40 ratio decreased, p-tau181 and GFAP increased in predicting the β-amyloid positive/negative status across the AD continuum.

ALZHEIMERS & DEMENTIA (2023)

Add to Collection

Article Multidisciplinary Sciences

Brain aerobic glycolysis and resilience in Alzheimer disease

Manu S. Goyal et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Add to Collection

Article Nutrition & Dietetics

Beta-Hydroxybutyrate (BHB), Glucose, Insulin, Octanoate (C8), and Decanoate (C10) Responses to a Medium-Chain Triglyceride (MCT) Oil with and without Glucose: A Single-Center Study in Healthy Adults

Christina Heidt et al.

Summary: This single-center study investigated the impact of consuming carbohydrate as glucose with MCT oil compared to MCT alone on the BHB response. The results showed that consuming MCT oil alone significantly increased BHB levels, while consuming MCT oil with glucose delayed the peak of BHB and led to increased blood glucose and insulin levels.

NUTRIENTS (2023)

Add to Collection

Review Neurosciences

Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases

Sina Shadfar et al.

Summary: Redox homeostasis refers to the balance between the production and elimination of reactive oxygen and nitrogen species, and it is crucial for cellular activities. Oxidative stress, caused by an imbalance between pro-oxidants and antioxidants, disrupts cellular functions, including DNA integrity maintenance. DNA damage and deficiencies in DNA repair are commonly observed in aging-related neurodegenerative diseases, such as Alzheimer's, Parkinson's, ALS, and Huntington's. This review discusses the emerging connections between redox dysregulation and DNA damage in these disorders, and highlights the importance of understanding these associations for developing therapeutic strategies.

TRANSLATIONAL NEURODEGENERATION (2023)

Add to Collection

Article Medicine, Research & Experimental

KATP channels are necessary for glucose- dependent increases in amyloid-β and Alzheimer's disease-related pathology

John Grizzanti et al.

Summary: Elevated blood glucose levels can increase brain excitability and A beta release, linking type 2 diabetes and Alzheimer's disease. The KATP channels, which couple energy availability with cellular excitability, play a role in AD pathogenesis. Manipulation of Kir6.2-KATP channels may hold therapeutic promise in reducing A beta pathology in patients with diabetes or prediabetes.

JCI INSIGHT (2023)

Add to Collection

Article Neurosciences

?-hydroxybutyrate improves cognitive impairment caused by chronic cerebral hypoperfusion via amelioration of neuroinflammation and blood-brain barrier damage

Zhitian Wang et al.

Summary: The present study aimed to investigate the potential mechanism by which beta-hydroxybutyrate (BHB) improves cognitive impairment caused by chronic cerebral hypoperfusion (CCH). The results showed that BHB intervention effectively restored hippocampal blood flow and improved spatial learning and memory in CCH rats. Furthermore, BHB protected the blood-brain barrier (BBB) and reduced neuroinflammation, highlighting its potential as a therapeutic agent for VCI.

BRAIN RESEARCH BULLETIN (2023)

Add to Collection

Article Neurosciences

Human Alzheimer's disease reactive astrocytes exhibit a loss of homeostastic gene expression

David L. Dai et al.

Summary: Astrocytes play a crucial role in maintaining neuronal homeostasis and modulating synaptic activity. In neurodegenerative diseases like Alzheimer's, reactive astrocytes with hypertrophic appearance are observed, but the molecular changes in these astrocytes have not been well studied. Using single nucleus RNA sequencing data, this study identified transcriptomic changes associated with astrocyte reactivity in Alzheimer's disease. The findings reveal a spectrum of reactivity within astrocytes, characterized by downregulation of homeostatic genes and upregulation of genes associated with inflammation and cellular growth. The study also confirmed the downregulation of ERBB4 and transcription factor NFIA in reactive astrocytes.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2023)

Add to Collection

Article Endocrinology & Metabolism

Hepatic sialic acid synthesis modulates glucose homeostasis in both liver and skeletal muscle

Jun Peng et al.

Summary: The synthesis and sialylation of sialic acid in the liver play a critical role in regulating hepatic glucose metabolism.

MOLECULAR METABOLISM (2023)

Add to Collection

Article Clinical Neurology

Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group

Inge M. W. Verberk et al.

Summary: Pre-analytical sample handling can impact Alzheimer's disease blood-based biomarkers. Different collection tube types resulted in varying values of assessed markers, with delayed centrifugation and storage affecting A beta and t-tau. Standardized operating procedures for plasma handling were constructed to facilitate the incorporation of blood-based biomarkers into research and clinical settings.

ALZHEIMERS & DEMENTIA (2022)

Add to Collection

Review Food Science & Technology

Medium chain triglycerides (MCT): State-of-the-art on chemistry, synthesis, health benefits and applications in food industry

Shubham Nimbkar et al.

Summary: This article reviews the common sources, extraction methods, and biological effects of MCT oil, as well as its application trends in food and nutraceuticals. Although there is debate about the health benefits of MCT oil, research on its extraction, processing, and storage methods continues.

COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY (2022)

Add to Collection

Article Neurosciences

The ketone ester, 3-hydroxybutyl-3-hydroxybutyrate, attenuates neurobehavioral deficits and improves neuropathology following controlled cortical impact in male rats

Camila Almeida-Suhett et al.

Summary: Ketone ester supplementation with 3-hydroxybutyl-3-hydroxybutyrate (KE) was found to have a neuroprotective effect in the treatment of traumatic brain injury (TBI). Experimental results showed that administration of KE significantly reduced the severity of motor and sensory deficits, decreased the lesion volume, and reduced pathological changes in the brain.

NUTRITIONAL NEUROSCIENCE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Effects of ketogenic diet on cognitive functions of mice fed high-fat-high-cholesterol diet

Dai-Ting Lin et al.

Summary: This study investigated the effects of a ketogenic diet (medium chain triglyceride, MCT) on cognitive performance after long-term consumption of a high-fat-high-cholesterol diet. The results showed that the MCT diet improved spatial learning and memory performance, reduced expression of inflammatory proteins, and increased expression of neurotrophic factors compared to the high-fat-high-cholesterol diet. This suggests that the MCT diet may help slow down neurodegeneration.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2022)

Add to Collection

Review Physiology

Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives

Elidie Beard et al.

Summary: Astrocytes play a key role in regulating brain energy metabolism, and dysregulation of astrocyte-mediated metabolic pathways is involved in brain hypometabolism. This is a common feature in various neurological pathologies.

FRONTIERS IN PHYSIOLOGY (2022)

Add to Collection

Article Clinical Neurology

Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease

Pratishtha Chatterjee et al.

Summary: This study found that GFAP and p-tau have good diagnostic and longitudinal monitoring potential in preclinical Alzheimer's disease. Combining GFAP with other proteins can improve diagnostic accuracy.

ALZHEIMERS & DEMENTIA (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Biomarkers for Alzheimer's Disease in the Current State: A Narrative Review

Serafettin Gunes et al.

Summary: Early diagnosis is crucial for delaying the onset of Alzheimer's disease, and current diagnostic methods are invasive and expensive, highlighting the need for more convenient and effective biomarkers. Studies have identified potential biomarkers, but further validation research is necessary.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

The Complex Mechanisms by Which Neurons Die Following DNA Damage in Neurodegenerative Diseases

Sina Shadfar et al.

Summary: DNA damage has significant consequences for cells, especially neurons. Aberrant DNA damage responses are increasingly observed in neurodegenerative diseases, and DNA repair declines with aging. Cell death mechanisms are linked to DNA damage and are particularly important for neurons.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Brain Metabolic Alterations in Alzheimer's Disease

Carlos G. Ardanaz et al.

Summary: The brain is an energy-consuming organ that relies on well-coordinated processes and molecular features for its energy supply. Age-related disruptions of these processes and neurodegenerative diseases can cause brain energy alterations, leading to cognitive decline. Understanding the metabolic dimension of healthy and diseased brains is crucial for developing effective prevention, diagnosis, and treatment strategies for neurodegenerative diseases like Alzheimer's.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Nutrition & Dietetics

The Therapeutic Role of Ketogenic Diet in Neurological Disorders

Diana Pietrzak et al.

Summary: The ketogenic diet may be a therapeutic option for neurological diseases by effectively controlling oxidative processes, neurotransmitter balance, inflammation, and gut microbiome composition.

NUTRIENTS (2022)

Add to Collection

Review Neurosciences

Advances in the development of new biomarkers for Alzheimer's disease

Timofey O. Klyucherev et al.

Summary: Alzheimer's disease is a complex and progressive neurodegenerative dementia. With the aging population, the prevalence of AD is expected to increase, posing greater burden on healthcare systems. There is a need for new diagnostic tests that can detect AD at an early stage with high specificity and low cost. Recent developments in blood, plasma, and ocular biomarkers show promising potential for the diagnosis of AD.

TRANSLATIONAL NEURODEGENERATION (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Ketone Bodies as Metabolites and Signalling Molecules at the Crossroad between Inflammation and Epigenetic Control of Cardiometabolic Disorders

Nadia Bendridi et al.

Summary: This review discusses the impact of diet on inflammatory environment and chronic diseases, as well as the potential of a no-carbohydrate ketogenic diet as a solution. Research has shown that ketone bodies modulate inflammation and influence gene transcription. Additionally, epigenome and chromatin remodeling may also play a key role in these processes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer's continuum

Gemma Salvado et al.

Summary: This study aimed to investigate the association between GFAP and reactive astrogliosis with glucose consumption. The results showed that plasma GFAP was positively associated with glucose consumption in the whole brain, while CSF GFAP was only associated with glucose uptake in specific smaller areas. These associations persisted after accounting for Aβ pathology, but became negative in Aβ and tau-positive participants in similar areas of AD-related hypometabolism.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Lipid metabolism and storage in neuroglia: role in brain development and neurodegenerative diseases

Danying Yang et al.

Summary: The importance of neuroglia in maintaining normal brain function has been increasingly supported by evidence. Lipid droplets play an underestimated role in the development of neurodegenerative diseases. This paper reviews the metabolism and accumulation of major lipids in the brain, discusses the regulation of lipid accumulation in different brain cells, and explores the pathological factors that promote lipid droplet formation, such as oxidative stress, energy metabolism, and glial cell-neuron coupling.

CELL AND BIOSCIENCE (2022)

Add to Collection

Review Cell Biology

Innate Immune Cell Death in Neuroinflammation and Alzheimer's Disease

Yetirajam Rajesh et al.

Summary: Alzheimer's disease is a neurodegenerative disorder characterized by the formation of plaques and abnormalities in certain proteins. Immune cells play a crucial role in the development of the disease, as they can cause cell death and release proinflammatory cytokines. However, chronic inflammation can worsen the condition. Therefore, balancing the immune response is important for effectively clearing the abnormal proteins without inducing inflammation.

CELLS (2022)

Add to Collection

Review Cell Biology

Neurons: The Interplay between Cytoskeleton, Ion Channels/Transporters and Mitochondria

Paola Alberti et al.

Summary: Neurons are permanent cells that rely on finely tuned homeostasis for proper function, with microtubules playing a key role in cellular equilibrium by mobilizing molecular cargos. Alterations in cytoskeletal dynamics can impact neuronal excitability, highlighting the importance of understanding these processes in human diseases and neuronal functioning. Microscopic approaches for visualizing and assessing the cytoskeleton, particularly in mitochondrial trafficking, are essential for further research in this area.

CELLS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Fats, Friends or Foes: Investigating the Role of Short- and Medium-Chain Fatty Acids in Alzheimer's Disease

Aishat O. Ameen et al.

Summary: This study summarizes the roles of short-chain fatty acids and medium-chain fatty acids in Alzheimer's disease, comparing the main findings on these lipid species in established animal models and recently developed human cell models of this devastating disorder.

BIOMEDICINES (2022)

Add to Collection

Article Clinical Neurology

Use of medium chain triglyceride (MCT) oil in subjects with Alzheimer's disease: A randomized, double-blind, placebo-controlled, crossover study, with an open-label extension

Angela G. G. Juby et al.

Summary: This study observed the long-term use of MCT oil in Alzheimer's disease patients and found that 80% of patients had stable or improved cognition. Long-term use of MCT oil and age over 73 years had a positive effect on improving final cognitive function.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2022)

Add to Collection

Article Geriatrics & Gerontology

Acetoacetate Improves Memory in Alzheimer's Mice via Promoting Brain-Derived Neurotrophic Factor and Inhibiting Inflammation

Xiao-Jun Wu et al.

Summary: Acetoacetate injection improved spatial and recognition memory in familial AD mice, potentially through inhibition of the GPR43-pERK pathway and stimulation of BDNF expression.

AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2022)

Add to Collection

Article Endocrinology & Metabolism

Glia fuel neurons with locally synthesized ketone bodies to sustain memory under starvation

Bryon Silva et al.

Summary: Memory formation in the starved Drosophila brain undergoes adaptive plasticity, with glial-derived ketone bodies serving as an energy substrate for neurons in the olfactory memory centre.

NATURE METABOLISM (2022)

Add to Collection

Article Geriatrics & Gerontology

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases

Ziying Jiang et al.

Summary: The ketogenic diet is a beneficial dietary intervention for neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, ALS, and HD, by regulating neuroinflammation through various pathways.

AGING AND DISEASE (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Expanding Implementation Research to Prevent Chronic Diseases in Community Settings

Stephanie Mazzucca et al.

Annual Review of Public Health (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The effect of a 6-month ketogenic medium-chain triglyceride supplement on plasma cardiometabolic and inflammatory markers in mild cognitive impairment.

Etienne Myette-Cote et al.

Summary: This study found that a 6-month intervention with kMCT had minimal effect on cardiometabolic markers and peripheral inflammation in individuals with mild cognitive impairment (MCI).

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2021)

Add to Collection

Article Psychiatry

Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease

Pratishtha Chatterjee et al.

Summary: The study found that plasma GFAP levels are elevated in cognitively normal older adults at risk of AD, indicating that astrocytic damage or activation may start from the pre-symptomatic stage of the disease and is associated with brain Aβ load. The potential of plasma GFAP to contribute to a diagnostic blood biomarker panel, along with plasma Aβ 1-42/Aβ 1-40 ratios, for cognitively normal older adults at risk of AD was highlighted by the observations from the present study.

TRANSLATIONAL PSYCHIATRY (2021)

Add to Collection

Review Neurosciences

Reactive astrocytes as treatment targets in Alzheimer's disease-Systematic review of studies using the APPswePS1dE9 mouse model

Tamar Smit et al.

Summary: This review focuses on the impact of reactive astrocytes on cognitive function in Alzheimer's disease, using a mouse model to study the potential effects of targeting reactive astrocytes as a treatment for AD. Studies suggest that interventions targeting astrocytes can benefit cognition in AD.

GLIA (2021)

Add to Collection

Article Psychology, Biological

The effects of medium chain triglyceride (MCT) supplementation using a C8:C10 ratio of 30:70 on cognitive performance in healthy young adults

Jake S. Ashton et al.

Summary: The study aimed to investigate the effects of MCT ingestion on cognitive function in young, healthy adults. Results showed that MCT intake significantly improved cognitive task performance after 2-3 weeks, with minimal difference between the 12 g and 18 g MCT/day groups, suggesting a possible dose-response threshold at 12 g MCT/day when supplementing over a short period.

PHYSIOLOGY & BEHAVIOR (2021)

Add to Collection

Article Clinical Neurology

Randomized crossover trial of a modified ketogenic diet in Alzheimer's disease

Matthew C. L. Phillips et al.

Summary: In a study on Alzheimer's disease patients, a 12-week modified ketogenic diet was found to improve daily function and quality of life compared to a usual diet. The retention rate, adherence, and safety of the ketogenic diet were high, suggesting its potential benefits for AD patients. The diet also showed slight improvement in cognitive function according to the study.

ALZHEIMERS RESEARCH & THERAPY (2021)

Add to Collection

Review Geriatrics & Gerontology

Mitochondrial Dysfunction and Oxidative Stress in Alzheimer's Disease

Afzal Misrani et al.

Summary: Mitochondria play a pivotal role in cell viability, with changes in morphology and dysfunction being closely linked to the pathogenesis of diseases like Alzheimer's. Restoring mitochondrial function can potentially delay the progression of Alzheimer's disease.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Ketogenic Diet as a potential treatment for traumatic brain injury in mice

Meirav Har-Even et al.

Summary: The study suggests that a ketogenic diet may be neuroprotective in traumatic brain injury mouse models, leading to improved cognitive abilities, reduced neuronal degeneration, and attenuated astrocyte reactivity in specific brain regions. This indicates a potential new therapeutic strategy for treating TBI.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Clinical Neurology

Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum

Andrea L. Benedet et al.

Summary: The study suggests that plasma GFAP is a sensitive biomarker for detecting reactive astrogliosis and Aβ pathology in early stages of AD, outperforming CSF GFAP. Plasma GFAP levels accurately discriminate between Aβ-positive and Aβ-negative individuals, with higher accuracy than CSF GFAP.

JAMA NEUROLOGY (2021)

Add to Collection

Review Nutrition & Dietetics

Neuroprotection by the Ketogenic Diet: Evidence and Controversies

Sarah M. Gough et al.

Summary: The ketogenic diet is a high-fat low-carbohydrate diet that has been used for decades to treat metabolic disorders and refractory pediatric epilepsy. Recent research has shown that it has neuroprotective properties and can improve quality of life in patients with various neurological disorders such as multiple sclerosis and Alzheimer's disease. The major ketone bodies BHB and ACA are believed to play a key role in these beneficial effects through specific inflammatory proteins, transcription factors, and other mechanisms.

FRONTIERS IN NUTRITION (2021)

Add to Collection

Review Nutrition & Dietetics

Ketone Supplementation: Meeting the Needs of the Brain in an Energy Crisis

Angela M. Poff et al.

Summary: Ketones can serve as an alternative fuel for the brain, and dietary supplementation with exogenous ketones may improve cognitive and motor performance in neurological disorders.

FRONTIERS IN NUTRITION (2021)

Add to Collection

Article Multidisciplinary Sciences

The medium-chain fatty acid decanoic acid reduces oxidative stress levels in neuroblastoma cells

Janine Mett et al.

Summary: This study demonstrates that decanoic acid (10:0) can reduce oxidative stress levels in neuroblastoma cells, independent of ketone levels, potentially promoting neuronal health.

SCIENTIFIC REPORTS (2021)

Add to Collection

Review Neurosciences

A Systematic Review of Glucose Transport Alterations in Alzheimer's Disease

Natalia Kyrtata et al.

Summary: Alzheimer's disease is associated with alterations in glucose transporters, possibly leading to reduced glucose transport across the blood-brain barrier and cell membranes, resulting in glucose deprivation and accelerated cognitive decline. Studies suggest that anti-diabetic medications show promise in improving glucose transport capacity in AD patients.

FRONTIERS IN NEUROSCIENCE (2021)

Add to Collection

Article Nutrition & Dietetics

One Month of Classic Therapeutic Ketogenic Diet Decreases Short Chain Fatty Acids Production in Epileptic Patients

Cinzia Ferraris et al.

Summary: This study found that one month of ketogenic diet (KD) significantly reduced the production of short chain fatty acids (SCFA) in epileptic patients, while slightly decreasing the toxicity of fecal water. These results suggest a new avenue for investigation into the effects of KD on gut health.

FRONTIERS IN NUTRITION (2021)

Add to Collection

Article Clinical Neurology

Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease

Joana B. Pereira et al.

Summary: The study suggests that plasma GFAP concentration is associated with brain amyloid-beta pathology but not tau aggregation in Alzheimer's disease. This indicates that plasma GFAP may be incorporated into current hypothetical models of Alzheimer's disease pathogenesis and used as a non-invasive tool to detect early astrocytosis.

BRAIN (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Brain Glucose Transporters: Role in Pathogenesis and Potential Targets for the Treatment of Alzheimer's Disease

Leszek Szablewski

Summary: Alzheimer's disease is the most common cause of dementia in elderly people, with aging being a main risk factor. Impairment of brain energy and glucose hypometabolism are hallmarks of the disease. There are several hypotheses on the role of glucose hypometabolism in AD, but further investigations are needed on this subject.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Neurosciences

Relationship Between Amyloid-β Deposition and Blood-Brain Barrier Dysfunction in Alzheimer's Disease

Dong Wang et al.

Summary: Amyloid-beta is a significant factor in Alzheimer's disease, affecting the progression and prognosis. Its deposition damages the blood-brain barrier, while dysfunction of the barrier exacerbates Aβ accumulation. This review highlights the interactions and mechanisms between Aβ deposition and BBB damage in AD.

FRONTIERS IN CELLULAR NEUROSCIENCE (2021)

Add to Collection

Article Nutrition & Dietetics

An fMRI Investigation into the Effects of Ketogenic Medium-Chain Triglycerides on Cognitive Function in Elderly Adults: A Pilot Study

Yukihito Yomogida et al.

Summary: Evidence suggests that oral intake of medium-chain triglycerides (MCTs) may improve cognitive functions in elderly people by promoting the production of ketone bodies; however, the brain mechanisms underlying this effect are still not fully understood. This study found that MCT intake led to changes in brain function and morphology, affecting cognitive performance, particularly in regions associated with executive functions. The use of ketone bodies as an additional energy source may play a role in the cognitive improvement observed.

NUTRIENTS (2021)

Add to Collection

Article Geriatrics & Gerontology

Serum proBDNF Is Associated With Changes in the Ketone Body β-Hydroxybutyrate and Shows Superior Repeatability Over Mature BDNF: Secondary Outcomes From a Cross-Over Trial in Healthy Older Adults

Jakob Norgren et al.

Summary: The study found a link between changes in peripheral BHB and proBDNF in healthy older adults, while changes in mBDNF were independent of BHB levels. Replication is needed due to the small sample size, and future research on proBDNF as a predictor of brain health is encouraged based on excellent repeatability.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Add to Collection

Article Clinical Neurology

A ketogenic supplement improves white matter energy supply and processing speed in mild cognitive impairment

Maggie Roy et al.

Summary: This study found that a 6-month intervention with ketogenic medium chain triglyceride (kMCT) drink increased ketone uptake in white matter (WM) fascicles in participants with mild cognitive impairment (MCI). The improvement in processing speed was positively associated with WM ketone uptake, especially in the fornix fascicle.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2021)

Add to Collection

Review Clinical Neurology

Insight into the genetic etiology of Alzheimer's disease: A comprehensive review of the role of rare variants

Julie Hoogmartens et al.

Summary: Early-onset Alzheimer's disease (EOAD) is often linked to dominant disease-causing mutations, but they only account for a small fraction of patients, and familial EOAD does not always show clear autosomal dominant inheritance. Studies suggest that factors beyond the amyloid beta pathway are also crucial in AD pathophysiology.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2021)

Add to Collection

Review Clinical Neurology

The Epidemiology of Alzheimer's Disease Modifiable Risk Factors and Prevention

X. -X. Zhang et al.

Summary: Mild Alzheimer's disease is a leading cause of dementia with an irreversible neurodegenerative process influenced by genetic susceptibility and environmental factors. Targeting multiple risk factors in non-demented elderly people or even middle-aged individuals may prevent or delay the onset of Alzheimer's disease before clinical symptoms occur.

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2021)

Add to Collection

Article Clinical Neurology

A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT

Melanie Fortier et al.

Summary: Supplementation with ketogenic medium chain triglyceride (kMCT) drink significantly improved cognitive outcomes in mild cognitive impairment (MCI), possibly by increasing blood ketone levels. These data support further evaluation of MCI progression to Alzheimer's disease.

ALZHEIMERS & DEMENTIA (2021)

Add to Collection

Article Clinical Neurology

The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study

Valentina Bessi et al.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2020)

Add to Collection

Article Geriatrics & Gerontology

Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study

Bryan J. Neth et al.

NEUROBIOLOGY OF AGING (2020)

Add to Collection

Article Nutrition & Dietetics

Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4-/-: A double-blind, randomized, placebo-controlled crossover trial

Qing Xu et al.

CLINICAL NUTRITION (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Ketone Bodies Promote Amyloid-β1-40 Clearance in a Human in Vitro Blood-Brain Barrier Model

Romain Versele et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Clinical Neurology

Metabolic compartmentalization between astroglia and neurons in physiological and pathophysiological conditions of the neurovascular unit

Shinichi Takahashi

NEUROPATHOLOGY (2020)

Add to Collection

Article Nutrition & Dietetics

The Impact of Coconut Oil and Epigallocatechin Gallate on the Levels of IL-6, Anxiety and Disability in Multiple Sclerosis Patients

Jose Luis Platero et al.

NUTRIENTS (2020)

Add to Collection

Article Nutrition & Dietetics

β-hydroxybutyrate Impedes the Progression of Alzheimer's Disease and Atherosclerosis in ApoE-Deficient Mice

Manigandan Krishnan et al.

NUTRIENTS (2020)

Add to Collection

Article Behavioral Sciences

Redistribution of Monocarboxylate 1 and 4 in Hippocampus and Spatial Memory Impairment Induced by Long-term Ketamine Administration

Runtao Ding et al.

FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2020)

Add to Collection

Article Clinical Neurology

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling data from four cohorts

Thomas K. Karikari et al.

LANCET NEUROLOGY (2020)

Add to Collection

Review Endocrinology & Metabolism

Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature

Mikiko Watanabe et al.

OBESITY REVIEWS (2020)

Add to Collection

Article Clinical Neurology

Estimating the potential for dementia prevention through modifiable risk factors elimination in the real-world setting: a population-based study

Elena Rolandi et al.

ALZHEIMERS RESEARCH & THERAPY (2020)

Add to Collection

Review Geriatrics & Gerontology

Mitochondrial Dysfunction and Alzheimer's Disease: Role of Microglia

Ishan Agrawal et al.

FRONTIERS IN AGING NEUROSCIENCE (2020)

Add to Collection

Review Health Care Sciences & Services

Biomarkers for Alzheimer's Disease Early Diagnosis

Eva Auso et al.

JOURNAL OF PERSONALIZED MEDICINE (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases

Nicole Jacqueline Jensen et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Clinical Neurology

Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease

Kunal Dhiman et al.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2020)

Add to Collection

Article Medicine, Research & Experimental

Biomarkers: Our Path Towards a Cure for Alzheimer Disease

Rawan Tarawneh

BIOMARKER INSIGHTS (2020)

Add to Collection

Review Clinical Neurology

Ketogenic diet, neuroprotection, and antiepileptogenesis

Madhuvika Murugan et al.

EPILEPSY RESEARCH (2020)

Add to Collection

Article Clinical Neurology

Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer's disease

Min Seok Baek et al.

ALZHEIMERS RESEARCH & THERAPY (2020)

Add to Collection

Review Psychiatry

Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders

Gerwyn Morris et al.

EUROPEAN PSYCHIATRY (2020)

Add to Collection

Article Neurosciences

Mechanisms for the maintenance and regulation of axonal energy supply

Kelly Anne Chamberlain et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2019)

Add to Collection

Review Neurosciences

Ketogenic Diet and Epilepsy: What We Know So Far

Isabella D'Andrea Meira et al.

FRONTIERS IN NEUROSCIENCE (2019)

Add to Collection

Article Multidisciplinary Sciences

A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease

Nicholas J. Ashton et al.

SCIENCE ADVANCES (2019)

Add to Collection

Article Clinical Neurology

A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment

Melanie Fortier et al.

ALZHEIMERS & DEMENTIA (2019)

Add to Collection

Review Clinical Neurology

Neurofilament light chain as a biomarker in neurological disorders

Lorenzo Gaetani et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Add to Collection

Review Clinical Neurology

Advantages and disadvantages of the use of the CSF Amyloid (A) 42/40 ratio in the diagnosis of Alzheimer's Disease

Oskar Hansson et al.

ALZHEIMERS RESEARCH & THERAPY (2019)

Add to Collection

Article Clinical Neurology

Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype

Lisa Vermunt et al.

ALZHEIMERS & DEMENTIA (2019)

Add to Collection

Article Neurosciences

Memory impairments and increased GFAP expression in hippocampal astrocytes following hypercaloric diet in rats

Eduardo Fernandes Bondan et al.

ARQUIVOS DE NEURO-PSIQUIATRIA (2019)

Add to Collection

Article Medicine, General & Internal

Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment

Ravinder Nagpal et al.

EBIOMEDICINE (2019)

Add to Collection

Review Medicine, General & Internal

Diagnosis and Management of Dementia: Review

Zoe Arvanitakis et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Add to Collection

Review Nutrition & Dietetics

Dietary Neuroketotherapeutics for Alzheimer's Disease: An Evidence Update and the Potential Role for Diet Quality

Matthew K. Taylor et al.

NUTRIENTS (2019)

Add to Collection

Editorial Material Nutrition & Dietetics

Ketogenic Diets and Exercise Performance

Kristin L. Harvey et al.

NUTRIENTS (2019)

Add to Collection

Review Physiology

BRAIN GLUCOSE METABOLISM: INTEGRATION OF ENERGETICS WITH FUNCTION

Gerald A. Dienel

PHYSIOLOGICAL REVIEWS (2019)

Add to Collection

Review Nutrition & Dietetics

Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease)

Dariusz Wlodarek

NUTRIENTS (2019)

Add to Collection

Article Nutrition & Dietetics

Plasma Ketone and Medium Chain Fatty Acid Response in Humans Consuming Different Medium Chain Triglycerides During a Metabolic Study Day

Valerie St-Pierre et al.

FRONTIERS IN NUTRITION (2019)

Add to Collection

Article Immunology

Short A beta peptides attenuate A beta 42 toxicity in vivo

Brenda D. Moore et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Add to Collection

Article Clinical Neurology

Evidence for brain glucose dysregulation in Alzheimer's disease

Yang An et al.

ALZHEIMERS & DEMENTIA (2018)

Add to Collection

Article Immunology

The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM

Steffen E. Storck et al.

BRAIN BEHAVIOR AND IMMUNITY (2018)

Add to Collection

Review Geriatrics & Gerontology

Deciphering the Astrocyte Reaction in Alzheimer's Disease

Beatriz G. Perez-Nievas et al.

FRONTIERS IN AGING NEUROSCIENCE (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Intake of medium-chain fatty acids induces myocardial oxidative stress and atrophy

Yoshihiro Miyagawa et al.

LIPIDS IN HEALTH AND DISEASE (2018)

Add to Collection

Review Neurosciences

Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons

Ravi Rajmohan et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Add to Collection

Review Biochemistry & Molecular Biology

The role of astrocytes in amyloid production and Alzheimer's disease

Georgia R. Frost et al.

OPEN BIOLOGY (2017)

Add to Collection

Article Clinical Neurology

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

Niklas Mattsson et al.

JAMA NEUROLOGY (2017)

Add to Collection

Article Neurosciences

Alzheimer's Disease and the Amyloid-β Peptide

M. Paul Murphy et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Add to Collection

Review Physiology

Fatty acid-induced astrocyte ketone production and the control of food intake

Christelle Le Foll et al.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2016)

Add to Collection

Article Clinical Neurology

Molecular Basis of Familial and Sporadic Alzheimer's Disease

Jolanta Dorszewska et al.

CURRENT ALZHEIMER RESEARCH (2016)

Add to Collection

Article Chemistry, Applied

Lauric Acid Stimulates Ketone Body Production in the KT-5 Astrocyte Cell Line

Yudai Nonaka et al.

Journal of Oleo Science (2016)

Add to Collection

Article Geriatrics & Gerontology

Ketones block amyloid entry and improve cognition in an Alzheimer's model

Jun Xiang Yin et al.

NEUROBIOLOGY OF AGING (2016)

Add to Collection

Article Neurosciences

Effect of a ketogenic meal on cognitive function in elderly adults: potential for cognitive enhancement

Miho Ota et al.

PSYCHOPHARMACOLOGY (2016)

Add to Collection

Review Neurosciences

Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms

Fan Su et al.

NEUROSCIENCE BULLETIN (2016)

Add to Collection

Article Neurosciences

Astrocyte Hypertrophy Contributes to Aberrant Neurogenesis after Traumatic Brain Injury

Clark Robinson et al.

NEURAL PLASTICITY (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Aβ42 and Aβ40: similarities and differences

Tian Qiu et al.

JOURNAL OF PEPTIDE SCIENCE (2015)

Add to Collection

Article Biochemistry & Molecular Biology

The neuroprotective effects of β-hydroxybutyrate on Aβ-injected rat hippocampus in vivo and in Aβ-treated PC-12 cells in vitro

G. Xie et al.

FREE RADICAL RESEARCH (2015)

Add to Collection

Article Multidisciplinary Sciences

Ketones Prevent Oxidative Impairment of Hippocampal Synaptic Integrity through KATP Channels

Do Young Kim et al.

PLOS ONE (2015)

Add to Collection

Article Neurosciences

Coconut Oil Attenuates the Effects of Amyloid-beta on Cortical Neurons in vitro

Firoozeh Nafar et al.

JOURNAL OF ALZHEIMERS DISEASE (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Apoptosis in Alzheimer's Disease: An Understanding of the Physiology, Pathology and Therapeutic Avenues

M. Obulesu et al.

NEUROCHEMICAL RESEARCH (2014)

Add to Collection

Article Neurosciences

Low-Level Laser Therapy Rescues Dendrite Atrophy via Upregulating BDNF Expression: Implications for Alzheimer's Disease

Chengbo Meng et al.

JOURNAL OF NEUROSCIENCE (2013)

Add to Collection

Article Geriatrics & Gerontology

A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease

Yoshihiro Kashiwaya et al.

NEUROBIOLOGY OF AGING (2013)

Add to Collection

Review Biochemistry & Molecular Biology

Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease

Sang-Sun Yoon et al.

BIOMOLECULES & THERAPEUTICS (2012)

Add to Collection

Article Geriatrics & Gerontology

Dietary ketosis enhances memory in mild cognitive impairment

Robert Krikorian et al.

NEUROBIOLOGY OF AGING (2012)

Add to Collection

Article Pharmacology & Pharmacy

Contributions of Brain Insulin Resistance and Deficiency in Amyloid-Related Neurodegeneration in Alzheimerʼs Disease

Suzanne M. de la Monte

DRUGS (2011)

Add to Collection

Article Neurosciences

Ketogenic diet-induced peroxisome proliferator-activated receptor-γ activation decreases neuroinflammation in the mouse hippocampus after kainic acid-induced seizures

Eun Ae Jeong et al.

EXPERIMENTAL NEUROLOGY (2011)

Add to Collection

Review Nutrition & Dietetics

Brain fuel metabolism, aging, and Alzheimer's disease

Stephen Cunnane et al.

NUTRITION (2011)

Add to Collection

Article Medicine, Research & Experimental

Neuropathological Alterations in Alzheimer Disease

Alberto Serrano-Pozo et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)

Add to Collection

Article Pediatrics

KETOGENIC DIETS IN THE TREATMENT OF EPILEPSY: SHORT-TERM CLINICAL EFFECTS

Ruby H. Schwartz et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2010)

Add to Collection

Article Clinical Neurology

A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy

Elizabeth G. Neal et al.

EPILEPSIA (2009)

Add to Collection

Article Clinical Neurology

The ketogenic diet: Uses in epilepsy and other neurologic illnesses

Kristin W. Barañano et al.

Current Treatment Options in Neurology (2008)

Add to Collection

Review Clinical Neurology

Anticonvulsant mechanisms of the ketogenic diet

Kristopher J. Bough et al.

EPILEPSIA (2007)

Add to Collection

Review Medicine, Research & Experimental

A mitochondrial cascade hypthesis for sporadic Alzheimer's disease

RH Swerdlow et al.

MEDICAL HYPOTHESES (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.